All hypotheses

In B7-expressing tumors, the minimum effective dose of anti-CTLA-4 immunotherapy is positively correlated with the baseline density of CTLA-4-expressing T cells within the tumor microenvironment, as CTLA-4's higher binding affinity for B7 ligands enables it to competitively sequester costimulatory signals away from CD28, and antibody-mediated blockade must overcome this affinity-based inhibition to restore CD28-driven T-cell activation and tumor rejection.

IV: Baseline density of CTLA-4-expressing T cells in the tumor microenvironment and dose of anti-CTLA-4 antibody
DV: Tumor rejection rate and T-cell proliferation index
Measure: Tumor volume over time, survival curves, and flow cytometric quantification of CTLA-4+ CD3+ T cells and CD28:B7 co-engagement in tumor infiltrates
Refuted if: If the minimum effective dose of anti-CTLA-4 antibody shows no correlation with CTLA-4+ T-cell density, or if blocking CTLA-4 does not increase CD28:B7 co-engagement or T-cell proliferation in B7-expressing tumors, the hypothesis is falsified.
Mechanism: CTLA-4 is induced upon T-cell activation and binds the B7 ligand with higher affinity than CD28, allowing it to outcompete CD28 for costimulatory signals and deliver inhibitory signals to T cells. Tumors expressing B7 can trigger rejection via CD28 costimulation, but CTLA-4 dominance suppresses this. Anti-CTLA-4 antibodies block CTLA-4, releasing B7 ligands for CD28 binding, thereby restoring the costimulatory signal required for T-cell activation and tumor rejection. Higher CTLA-4 density increases the number of B7 ligands sequestered, requiring higher antibody doses to achieve sufficient blockade.

Quantitative prediction: Administer escalating doses of anti-CTLA-4 antibody to mice with B7-expressing tumors stratified by low vs. high intratumoral CTLA-4+ T-cell density → increase 2–5 fold in Tumor rejection rate and T-cell proliferation index · confidence 0.75 · support 4 / contra 0

The efficacy of anti-CTLA-4 immunotherapy is positively correlated with the density of B7 ligand expression on infiltrating antigen-presenting cells within the tumor microenvironment, as the drug functions by competitively blocking CTLA-4-mediated inhibition of the B7:CD28 costimulatory pathway, and sufficient B7 availability on APCs is required to sustain the CD28-driven T-cell activation and IL-2 production necessary for antitumor rejection.

IV: B7 ligand density on infiltrating antigen-presenting cells
DV: Clinical response rate to anti-CTLA-4
Measure: B7 expression quantified by immunohistochemistry on tumor sections; response assessed by RECIST criteria
Refuted if: No significant correlation (odds ratio = 1) or negative correlation (odds ratio < 1) between B7 density on APCs and response rate
Mechanism: CTLA-4 binds B7 with higher affinity than CD28 (linsley1991), and CTLA-4:B7 engagement delivers an inhibitory signal to T cells (walunas1994). Anti-CTLA-4 antibodies block this interaction, freeing B7 ligands for CD28 binding. The B7:CD28 interaction is required for full T-cell activation and IL-2 production (boussiotis1994), and B7 costimulation triggers protective antitumor immunity (chen1992). Since tumors often fail to provide costimulatory signals (boussiotis1994), APCs are the primary source of B7; thus, higher APC B7 density provides more substrate for the drug to act upon, enhancing CD28-mediated T-cell activation and tumor rejection.

Quantitative prediction: Stratify patients by B7 density on APCs (high vs. low) → increase 1.5–2.5 fold increase in odds of response in Clinical response rate to anti-CTLA-4 · confidence 0.75 · support 4 / contra 0

The antitumor efficacy of anti-CTLA-4 immunotherapy is strictly mediated by IL-2 production, such that pharmacological neutralization of IL-2 abolishes tumor rejection despite effective CTLA-4 blockade and restored CD28 costimulatory signaling.

IV: IL-2 availability (neutralized via anti-IL-2R antibody vs. available)
DV: Tumor rejection rate
Measure: Tumor regression incidence and intratumoral IL-2 concentration measured by ELISA or flow cytometry
Refuted if: Tumor rejection occurs at rates statistically indistinguishable from the anti-CTLA-4 monotherapy group despite confirmed IL-2 neutralization (IL-2 levels < detection limit)
Mechanism: Anti-CTLA-4 antibodies block CTLA-4 engagement with B7 ligands, relieving the inhibitory signal and allowing CD28 to engage B7. The CD28:B7 interaction is required for full T-cell activation and IL-2 transcription. IL-2 is necessary for T-cell proliferation and effector function. Without IL-2, T cells cannot execute tumor cell killing even if the costimulatory signal is restored via CTLA-4 blockade.

Quantitative prediction: Co-administration of anti-IL-2R antibody with anti-CTLA-4 mAb in B7+ tumor-bearing mice → decrease 85–95 % in Tumor rejection rate · confidence 0.75 · support 4 / contra 0

Increasing cd28 produces a measurable change in ctla-4.

IV: cd28
DV: ctla-4

compile errors: missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

Increasing activation produces a measurable change in t-cell.

IV: activation
DV: t-cell

compile errors: missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

Increasing ctla-4 produces a measurable change in t-cell.

IV: ctla-4
DV: t-cell

compile errors: missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

Co-administration of the CXCR4 antagonist Plerixafor with anti-PD-1 immunotherapy overcomes primary resistance in melanoma by dismantling the CXCL12-mediated cancer-associated fibroblast barrier, resulting in a significant increase in intratumoral CD8+ T cell infiltration and objective response rates.

IV: Administration of Plerixafor (10 mg/kg/day subcutaneously) combined with anti-PD-1 (Nivolumab 1 mg/kg IV every 2 weeks) versus anti-PD-1 monotherapy.
DV: Intratumoral CD8+ T cell density (cells/mm²) and Objective Response Rate (ORR).
Measure: Paired tumor biopsies at baseline and Day 28 analyzed via multiplex immunofluorescence (mIF) for CD8, CXCR4, and α-SMA; RECIST 1.1 criteria for ORR assessed at 16 weeks.
Refuted if: If the combination arm shows no significant difference in intratumoral CD8+ T cell density (p > 0.05) or ORR compared to the monotherapy arm, the hypothesis is falsified.
Mechanism: CXCL12 secreted by cancer-associated fibroblasts (CAFs) recruits CXCR4-expressing stromal cells and creates a chemokine barrier that physically excludes CD8+ T cells from the tumor parenchyma. CXCR4 antagonism disrupts this stromal compartment and neutralizes the chemotactic exclusion signal, thereby permitting T cell infiltration and restoring anti-PD-1 efficacy.

compile errors: missing:prediction, evidence:ungrounded (no source_ids)

There is a relationship between: 'B7-mediated costimulation is required for full T-cell activation and IL-2 production.' and 'The B7:CD28 pathway is a critical control point for T-cell responses.'.

compile errors: missing:independent_variable, missing:dependent_variable, missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

There is a relationship between: 'CTLA-4 opposes the stimulatory function of CD28.' and 'T-cell costimulation can generate protective antitumor immunity.'.

compile errors: missing:independent_variable, missing:dependent_variable, missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

There is a relationship between: 'B7-mediated costimulation is required for full T-cell activation and IL-2 production.' and 'CD28 ligation augments T-cell responses while CTLA-4 ligation inhibits them.'.

compile errors: missing:independent_variable, missing:dependent_variable, missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

In deuterium-loaded palladium electrodes at ambient temperature, the branching ratio of the neutron-emitting D-D fusion channel (D+D→³He+n) relative to the proton-emitting channel (D+D→T+p) will increase monotonically with the deuterium-to-palladium atomic loading ratio, because high deuteron density in the metal lattice enhances many-body electronic screening that narrows the effective Coulomb barrier and differentially boosts the Gamow tunneling probability for the higher-Q-value neutron branch.

IV: Deuterium-to-palladium atomic loading ratio (D/Pd) in the electrode lattice
DV: Neutron-to-proton D-D fusion branch yield ratio (³He+n events / T+p events)
Measure: Simultaneous quantification of 2.45 MeV neutrons (via ³He proportional counter) and 1.01 MeV tritons (via silicon surface-barrier detector or CR-39 track etch) normalized to incident deuteron flux and electrode mass, computed as the ratio of branch-specific counts over fixed integration windows at each loading step
Refuted if: If the neutron-to-proton branch ratio shows no statistically significant change (p>0.05, absolute Δ<5%) across the full D/Pd loading range from 0.40 to 0.95, or if the proton branch is preferentially enhanced at higher loadings, the hypothesis is falsified
Mechanism: Graham establishes that palladium accommodates extremely high densities of absorbed hydrogen isotopes within its metal lattice, compressing inter-nuclear spacing as the loading ratio rises. Gamow demonstrates that low-energy nuclear reaction rates are governed by quantum tunneling through the Coulomb barrier, with tunneling probability falling off exponentially with barrier width and height. The dense conduction-electron sea in palladium screens the deuteron-deuteron repulsion, effectively reducing both barrier width and height. Because the neutron-emitting branch (Q=3.27 MeV) and proton-emitting branch (Q=4.03 MeV) differ in exit-channel Q-values and Coulomb barriers for the charged products, the screened Gamow factor increases the relative tunneling probability of the neutron branch more than the charged proton branch. Oliphant documents both characteristic D-D fusion branches and their distinct product signatures, providing the measurable observables for the predicted ratio shift.

Quantitative prediction: Stepwise electrochemical or gas-phase loading of deuterium into a palladium electrode, increasing the D/Pd atomic ratio from 0.60 to 0.90 in 0.10 increments at 298 K → increase 12–28 % in Neutron-to-proton D-D fusion branch yield ratio (³He+n events / T+p events) · confidence 0.42 · support 3 / contra 0

Deuterium-loaded palladium electrodes at ambient temperature will exhibit a measurable increase in D-D fusion neutron yield that scales exponentially with the reduction in average deuteron-deuteron inter-nuclear spacing within the metal lattice.

IV: Average deuteron-deuteron inter-nuclear spacing in the palladium lattice, manipulated via deuterium gas pressure during electrochemical or gas-phase loading.
DV: Room-temperature deuterium-deuterium fusion neutron emission rate.
Measure: Thermal neutron flux measured by a calibrated ^3He proportional counter at a fixed 10 cm distance, normalized to electrode surface area and corrected for ambient cosmic/neutron background over a 24-hour integration window.
Refuted if: If neutron counts show no statistically significant increase (p>0.05, two-tailed Poisson test) above background when D-D spacing is confirmed via X-ray diffraction to be below 1.1 Å, or if the yield scaling with inverse spacing deviates significantly from an exponential function (R²<0.7), the hypothesis is falsified.
Mechanism: Per Graham (1866), palladium can absorb and hold deuterium at extreme lattice densities, packing deuterons into close interstitial sites. Per Gamow (1928), the probability of quantum tunneling through a repulsive barrier falls off exponentially with barrier width; compressing the lattice narrows the effective Coulomb barrier between adjacent deuterons, thereby exponentially increasing the tunneling probability. Per Oliphant (1934), once the barrier is penetrated, deuterons undergo fusion branches that emit neutrons. The combined effect predicts that lattice-driven barrier narrowing will produce a room-temperature neutron flux that scales exponentially with deuteron packing density.

Quantitative prediction: Increase deuterium gas pressure from 1 atm to 100 atm during palladium electrode loading at 298 K for 72 hours. → increase 1000–5000 % in Room-temperature deuterium-deuterium fusion neutron emission rate. · confidence 0.15 · support 3 / contra 0

In deuterium-loaded palladium electrodes, the D-D fusion neutron yield will decrease exponentially with increasing temperature between 20°C and 80°C, because thermal reduction of lattice deuteron density widens the effective Coulomb barrier and suppresses the Gamow tunneling probability.

IV: Electrode temperature (20–80°C)
DV: D-D fusion neutron emission rate normalized to electrode mass
Measure: Absolute neutron count rate (n·s⁻¹·g⁻¹) captured by a calibrated ³He proportional counter with pulse-shape discrimination, normalized to electrode dry mass and corrected for geometric efficiency
Refuted if: If the normalized neutron yield increases monotonically with temperature across the 20–80°C range, or shows no statistically significant correlation (p>0.05, two-tailed) with independently measured deuterium loading fraction via gravimetric or electrochemical titration, the hypothesis is falsified
Mechanism: Graham establishes that palladium absorbs and retains hydrogen isotopes at high lattice density, making deuteron number density the primary substrate for any solid-state fusion. Oliphant establishes that D-D fusion requires overcoming the Coulomb barrier between nuclei. Gamow establishes that sub-barrier fusion proceeds via quantum tunneling, with probability falling off exponentially with barrier width and height. As electrode temperature rises, thermal energy reduces deuterium solubility in the Pd lattice (per Graham’s absorption dynamics), increasing the average inter-deuteron spacing. This spacing increase effectively widens the Coulomb barrier between adjacent deuterons, which exponentially suppresses the Gamow tunneling probability, thereby reducing the D-D fusion rate per unit volume.

Quantitative prediction: Increment electrode temperature by 10°C steps from 20°C to 80°C while maintaining constant D₂O vapor pressure and palladium loading → decrease 12–28 % per 10°C in D-D fusion neutron emission rate normalized to electrode mass · confidence 0.32 · support 3 / contra 0

Increasing hydrogen produces a measurable change in palladium.

IV: hydrogen
DV: palladium

compile errors: missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

Increasing probability produces a measurable change in tunneling.

IV: probability
DV: tunneling

compile errors: missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

Increasing barrier produces a measurable change in tunneling.

IV: barrier
DV: tunneling

compile errors: missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

There is a relationship between: 'Quantum tunneling allows a small probability of barrier penetration below the classical threshold.' and 'Nuclear reaction rates at low energy are governed by the Gamow factor.'.

compile errors: missing:independent_variable, missing:dependent_variable, missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

There is a relationship between: 'Fusion of deuterons yields tritium, helium-3, protons, and neutrons in characteristic branches.' and 'The tunneling probability falls off exponentially with barrier width and height.'.

compile errors: missing:independent_variable, missing:dependent_variable, missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

There is a relationship between: 'Fusion of deuterons yields tritium, helium-3, protons, and neutrons in characteristic branches.' and 'The tunneling probability falls off exponentially with barrier width and height.'.

compile errors: missing:independent_variable, missing:dependent_variable, missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

In a heterologous Escherichia coli host expressing the Streptococcus thermophilus type II CRISPR/Cas system, spacer position within the CRISPR array (leader-proximal vs. leader-distal) dictates the positional precision of Cas9-mediated double-strand breaks relative to the protospacer-PAM interface, because asymmetric pre-crRNA maturation kinetics driven by differential tracrRNA hybridization occupancy modulate the stoichiometric loading of functional crRNA-Cas9 complexes.

IV: Spacer position within the CRISPR array (leader-proximal vs. leader-distal)
DV: Positional precision of Cas9-mediated double-strand breaks relative to the protospacer-PAM interface
Measure: Next-generation sequencing of break junctions mapped to protospacer coordinates, quantified as the standard deviation (bp) of cut sites from the canonical cleavage position
Refuted if: If paired statistical comparison of cut-site SDs between proximal and distal spacer positions shows no significant difference (p > 0.05, Cohen's d < 0.3) or distal spacers show equal/narrower distributions, the hypothesis is rejected
Mechanism: The CRISPR array is transcribed into a polycistronic pre-crRNA in which leader-proximal spacers are positioned upstream and are released from the transcript earlier than leader-distal spacers. Because tracrRNA must base-pair with the repeat regions of pre-crRNA to enable RNase III-mediated maturation, transient tracrRNA availability during early processing phases preferentially saturates the more abundant upstream pre-crRNAs. This yields higher intracellular concentrations of mature crRNAs for proximal spacers, which in turn drives rapid, complete R-loop formation at the target DNA. Complete R-loops enforce precise positioning of the Cas9 HNH and RuvC nuclease domains relative to the protospacer-PAM interface, producing tightly clustered double-strand breaks. Conversely, leader-distal spacers are processed later and at lower yields, loading Cas9 substoichiometrically and permitting transient mismatch scanning that increases cleavage site heterogeneity.

Quantitative prediction: Compare NGS-derived cut-site distributions for a leader-proximal vs. leader-distal spacer targeting identical protospacer sequences in E. coli expressing the S. thermophilus type II locus → decrease 30–50 % in Positional precision of Cas9-mediated double-strand breaks relative to the protospacer-PAM interface · confidence 0.65 · support 4 / contra 0

In a heterologous Escherichia coli host expressing the Streptococcus thermophilus type II CRISPR/Cas system, expanding the CRISPR array beyond six spacers will produce a sublinear increase in Cas9-mediated double-strand break frequency at a single target protospacer, because trans-activating crRNA (tracrRNA) becomes rate-limiting for pre-crRNA processing, capping the stoichiometric loading of functional crRNAs onto Cas9.

IV: Number of spacers in the CRISPR array (1 to 10)
DV: Frequency of Cas9-mediated double-strand breaks at a defined target protospacer
Measure: Target-locus indel frequency quantified by deep amplicon sequencing, normalized to total cell count
Refuted if: If deep sequencing reveals that each additional spacer from 6 to 10 continues to increase target-locus indel frequency by ≥1.5-fold relative to the previous array size, the hypothesis is rejected.
Mechanism: Each spacer in the CRISPR array requires independent tracrRNA base-pairing with its repeat region and subsequent Cas9/RNase III cleavage to generate a mature crRNA (deltcheva2011). As spacer count rises, the cellular tracrRNA pool becomes depleted relative to pre-crRNA demand, reducing the fraction of Cas9 molecules that can be loaded with a functional guide. Because Cas9 is the sole Cas protein required for interference in this heterologous system (sapranauskas2011), the rate of double-strand break introduction at the target protospacer (garneau2010) is directly proportional to the concentration of loaded Cas9-crRNA complexes. While spacer number dictates resistance specificity and phenotype magnitude (barrangou2007), the kinetics of tracrRNA-mediated maturation impose a hard stoichiometric ceiling on functional editing output in E. coli.

Quantitative prediction: Systematically expand the CRISPR array from 6 to 10 spacers in E. coli expressing the S. thermophilus type II locus → decrease 0–0.2 fold-increase per additional spacer beyond 6 in Frequency of Cas9-mediated double-strand breaks at a defined target protospacer · confidence 0.75 · support 4 / contra 0

Weakened thermodynamic stability of the tracrRNA-crRNA repeat hybrid quantitatively reduces Cas9-mediated double-strand break yield in a heterologous host without altering target sequence specificity.

IV: Thermodynamic stability (ΔG) of the tracrRNA-crRNA repeat hybrid, manipulated via point mutations in the CRISPR repeat sequence
DV: Cas9-mediated double-strand break (DSB) yield at the target protospacer site
Measure: Quantification of cleaved versus full-length target plasmid via quantitative PCR (qPCR), expressed as percentage of input plasmid cleaved
Refuted if: If repeat mutations that lower hybrid stability by ≥2.0 kcal/mol fail to reduce DSB yield by ≥30%, or if target specificity shifts, the hypothesis is falsified
Mechanism: The tracrRNA must base-pair with the repeat region of pre-crRNA to recruit Cas9 and RNase III for crRNA maturation (deltcheva2011). Reduced hybrid stability impairs this processing step, lowering the intracellular pool of mature crRNAs. Because mature crRNAs are the sole guides that direct Cas9 to complementary protospacer sequences via sequence complementarity (brouns2008; marraffini2008), their depletion decreases the frequency of Cas9 RuvC/HNH nuclease-mediated DNA cleavage (garneau2010; sapranauskas2011) without changing the recognition site of the remaining functional guides.

Quantitative prediction: Introduce point mutations in the CRISPR repeat sequence to reduce tracrRNA-crRNA hybrid stability by 1.0 kcal/mol relative to wild-type → decrease 25–40 % DSB yield reduction per kcal/mol in Cas9-mediated double-strand break (DSB) yield at the target protospacer site · confidence 0.55 · support 4 / contra 0

Increasing cas9 produces a measurable change in type.

IV: cas9
DV: type

compile errors: missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

Increasing crispr produces a measurable change in type.

IV: crispr
DV: type

compile errors: missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

Increasing system produces a measurable change in type.

IV: system
DV: type

compile errors: missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

There is a relationship between: 'A trans-activating CRISPR RNA (tracrRNA) is required for crRNA maturation in type II systems.' and 'tracrRNA base-pairs with the repeat portion of pre-crRNA.'.

compile errors: missing:independent_variable, missing:dependent_variable, missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

There is a relationship between: 'The mechanism is a nucleic-acid-guided immune process.' and 'Cas9 is the sole Cas protein required for interference in the type II system.'.

compile errors: missing:independent_variable, missing:dependent_variable, missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

There is a relationship between: 'A trans-activating CRISPR RNA (tracrRNA) is required for crRNA maturation in type II systems.' and 'The CRISPR/Cas system introduces double-strand breaks in target DNA.'.

compile errors: missing:independent_variable, missing:dependent_variable, missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

Targeted replacement of GU-rich TLR7/8 agonist motifs in liposome-formulated IVT mRNA with 5-methylcytidine will extend intracellular antigen half-life in vivo by 1.8-fold, thereby increasing antigen-specific germinal center B-cell frequencies by 40–60% compared to unmodified mRNA.

IV: Nucleoside composition at GU-rich motifs (uridine vs. 5-methylcytidine substitution)
DV: Intracellular antigen half-life and germinal center B-cell frequency
Measure: Intracellular OVA protein levels in muscle-derived cells quantified by flow cytometry over 0–48h, and OVA-specific GL7+CD44+ germinal center B cells quantified by flow cytometry in draining lymph nodes at day 7
Refuted if: If m5C substitution at GU-rich motifs fails to extend antigen half-life by ≥30% or does not increase GC B-cell frequency by ≥20% relative to unmodified mRNA, the hypothesis is rejected
Mechanism: Heil2004 establishes that GU-rich ssRNA sequences are potent TLR7/8 agonists, and diebold2004 shows TLR7 activation drives type I IFN and inflammatory cytokine production. Kariko2004 posits that cellular nucleoside modifications distinguish self from non-self RNA, while limbach1994 documents that mammalian RNAs are densely modified compared to IVT or bacterial RNAs. By substituting uridine with 5-methylcytidine specifically within GU-rich contexts, the mRNA mimics mammalian self-RNA, evading endosomal TLR7/8 sensing. Reduced innate immune activation prevents IFN-induced mRNA degradation and inflammatory cell recruitment, thereby prolonging the transient protein expression window originally described by wolff1990. Martinon1993 demonstrates that liposome delivery of mRNA sustains antigen presentation long enough to prime adaptive immunity; the extended antigen persistence will provide prolonged B-cell receptor signaling in draining lymph nodes, driving greater germinal center formation and B-cell expansion.

Quantitative prediction: Replace U with m5C at GU-rich motifs in liposome-formulated IVT mRNA → increase 1.8–2 fold in Intracellular antigen half-life and germinal center B-cell frequency · confidence 0.72 · support 6 / contra 0

Incorporating mammalian-typical nucleoside modifications into in-vitro-transcribed mRNA will decouple innate immune activation from antigen expression duration, shifting the immune output from a dominant type I interferon signature toward sustained cytotoxic T-cell priming.

IV: Degree of nucleoside modification in in-vitro-transcribed mRNA (unmodified uridine/cytidine vs. mammalian-mimetic substitution with pseudouridine and N1-methylpseudouridine)
DV: Ratio of antigen-specific CD8+ T-cell frequencies to peak type I interferon concentration in draining lymph nodes
Measure: Flow cytometry for antigen-specific H-2Kb tetramer+ CD8+ T cells in popliteal lymph nodes at day 7 post-injection; ELISA for IFN-α in lymph node homogenates at 6 hours post-injection
Refuted if: If modified mRNA yields a CD8+/IFN-α ratio that is ≤1.1-fold of unmodified mRNA, or if peak IFN-α drops by >60% relative to unmodified mRNA while CD8+ frequencies remain unchanged or increase, the hypothesis is falsified
Mechanism: Unmodified in-vitro-transcribed mRNA lacks the dense nucleoside modification patterns characteristic of endogenous mammalian RNA, causing endosomal TLR3 and TLR7 to recognize it as non-self and trigger NF-κB and type I interferon signaling. This innate burst accelerates mRNA degradation and restricts protein expression to a transient window in muscle. By replacing unmodified bases with mammalian-typical nucleosides, the mRNA evades TLR-mediated clearance, extends the window of intracellular antigen translation, and provides sustained substrate for dendritic cell cross-presentation, thereby maximizing antigen-specific CTL priming independent of the initial innate inflammatory spike.

Quantitative prediction: Substitution of 50% of uridine with pseudouridine and 25% of cytidine with N1-methylpseudouridine in liposome-formulated in-vitro-transcribed mRNA → increase 2.5–3.8 fold in Ratio of antigen-specific CD8+ T-cell frequencies to peak type I interferon concentration in draining lymph nodes · confidence 0.72 · support 6 / contra 0

Incorporating pseudouridine and N1-methylpseudouridine into in-vitro-transcribed mRNA will attenuate TLR7/8-mediated innate immune activation by 60–80% while preserving antigen-specific CD8+ T-cell priming in vivo.

IV: Nucleoside modification status of in-vitro-transcribed mRNA (unmodified uridine vs. pseudouridine/N1-methylpseudouridine substitution)
DV: TLR7/8-driven type I interferon production and antigen-specific CD8+ cytotoxic T lymphocyte expansion
Measure: Quantitative ELISA for IFN-α2 in cell culture supernatants and flow cytometric enumeration of model antigen-specific CD8+ T cells in splenocytes
Refuted if: If modified mRNA reduces IFN-α2 by less than 30%, or if CD8+ T cell expansion declines by more than 50% compared to unmodified mRNA, the hypothesis is rejected
Mechanism: Unmodified in-vitro-transcribed mRNA lacks the dense post-transcriptional nucleoside modifications characteristic of endogenous mammalian RNA, causing it to be recognized as non-self by endosomal TLR7 and TLR8. This recognition triggers MyD88-dependent NF-κB and IRF7 signaling, resulting in robust type I interferon and inflammatory cytokine release that can shunt translational resources toward stress responses and limit therapeutic utility. Substituting uridine with pseudouridine and N1-methylpseudouridine recapitulates the base composition and structural conformation of self-RNA, thereby evading TLR7/8 detection, dampening the innate inflammatory cascade, and allowing sustained ribosomal translation and efficient antigen processing for MHC-I-restricted CD8+ T-cell priming.

Quantitative prediction: Substitute 100% of uridine residues with pseudouridine and N1-methylpseudouridine in a model antigen mRNA → decrease 60–80 % in TLR7/8-driven type I interferon production and antigen-specific CD8+ cytotoxic T lymphocyte expansion · confidence 0.78 · support 5 / contra 0

Increasing induce produces a measurable change in mrna.

IV: induce
DV: mrna

compile errors: missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

Increasing mrna produces a measurable change in viral.

IV: mrna
DV: viral

compile errors: missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

Increasing expression produces a measurable change in mrna.

IV: expression
DV: mrna

compile errors: missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

Strategic co-incorporation of N6-methyladenosine (m6A) at a density of 1 modification per 200 nucleotides within the coding sequence of N1-methylpseudouridine (m1Ψ)-modified mRNA will significantly widen the therapeutic safety window by destabilizing immunostimulatory double-stranded RNA (dsRNA) secondary structures, resulting in >55% reduction in MDA5-dependent IFN-β secretion in human dendritic cells while maintaining antigen-specific CD8+ T-cell expansion within 10% of m1Ψ-mRNA controls in a murine model.

IV: Nucleoside composition of the mRNA: m1Ψ-mRNA with uniform m6A co-modification (m1Ψ+m6A) versus m1Ψ-mRNA without m6A (m1Ψ-only), matched for total nucleoside content and sequence.
DV: 1) Innate immune activation quantified by IFN-β and TNF-α secretion; 2) Vaccine potency quantified by antigen-specific CD8+ T-cell expansion and cytotoxic activity.
Measure: IFN-β and TNF-α measured by multiplex ELISA at 6 hours post-transfection; CD8+ T-cell expansion measured by flow cytometry using MHC-I tetramers specific for the model antigen (e.g., OVA257-264) and intracellular IFN-γ staining at day 7 post-immunization; dsRNA content assessed by immunofluorescence using the J2 antibody.
Refuted if: The hypothesis is falsified if: (1) m1Ψ+m6A mRNA induces IFN-β levels equal to or greater than m1Ψ-only mRNA; or (2) m1Ψ+m6A mRNA results in CD8+ T-cell expansion reduced by more than 10% relative to m1Ψ-only mRNA; or (3) J2 immunofluorescence shows no difference in dsRNA structural load between groups despite m6A incorporation.
Mechanism: The N6-methyl group on adenosine introduces steric hindrance and alters the electronic properties of the base, destabilizing A-U Watson-Crick base pairing and disrupting the formation of stable immunostimulatory dsRNA helices. By reducing the thermodynamic stability of these dsRNA motifs, m6A prevents the recruitment and activation of the cytosolic pattern recognition receptor MDA5, which senses long dsRNA structures, thereby dampening the downstream IFN-β signaling cascade without impeding ribosomal scanning or translation initiation.

compile errors: missing:prediction, evidence:ungrounded (no source_ids)

There is a relationship between: 'TLR7 and TLR8 recognize single-stranded RNA in a sequence- and species-dependent manner.' and 'GU-rich ssRNA sequences are potent TLR7/8 agonists.'.

compile errors: missing:independent_variable, missing:dependent_variable, missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

There is a relationship between: 'The innate immune system detects exogenous RNA as a danger signal.' and 'Exogenous mRNA is immunostimulatory, which limits its therapeutic use.'.

compile errors: missing:independent_variable, missing:dependent_variable, missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

There is a relationship between: 'TLR7 and TLR8 recognize single-stranded RNA in a sequence- and species-dependent manner.' and 'Single-stranded RNA activates innate immunity through TLR7.'.

compile errors: missing:independent_variable, missing:dependent_variable, missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

When normalized to the volume of active air component consumed, the mass of phlogiston exchanged is stoichiometrically conserved across combustion, respiration, and calcination, because the nitro-aerial particles that mediate flame dissolution and metal calx formation act as a universal phlogiston shuttle that transfers identical phlogiston equivalents per active-air unit regardless of the biological or chemical process.

IV: Nature of the air-consuming process (combustion, respiration, or calcination) in sealed vessels with identical initial air composition
DV: Mass of phlogiston exchanged per unit volume of active air component consumed
Measure: Volume of air depleted and net mass change of each system over fixed intervals, normalized to the independently determined active air fraction via Mayow-style nitro-aerial particle assays
Refuted if: If the phlogiston-exchange ratio per unit active air consumed differs by more than ±20% between combustion and respiration, or if calcination consumes a measurably different active air fraction than combustion/respiration, the hypothesis is rejected
Mechanism: Phlogiston is released during combustion and absorbed during respiration, with both processes drawing from the same finite reservoir of active air particles. These particles function as a phlogiston carrier: each active-air unit accepts or releases a fixed phlogiston equivalent. During calcination, the same active-air particles interact with the metal surface, but the metal's affinity for phlogiston causes net retention, producing the observed weight gain. Because the active-air-to-phlogiston transfer stoichiometry is invariant, normalizing mass exchange to active-air consumption yields a constant across all three phenomena.

Quantitative prediction: Run parallel sealed-vessel trials with candles, respiring animals, and calcining copper, measuring air depletion and system mass change, then normalize phlogiston exchange to the active air fraction consumed in each trial → change 0.85–1.15 fold in Mass of phlogiston exchanged per unit volume of active air component consumed · confidence 0.62 · support 3 / contra 0

The duration of a flame in a sealed vessel is linearly coupled to the mass gained by a calcining metal in the same vessel, because the active air component that 'dissolves' the flame is the identical substance that incorporates into the metal calx.

IV: Volume of the sealed glass vessel (which scales the total available active air component)
DV: Flame extinction time (seconds) per unit mass of metal calx gained (grains)
Measure: Mechanical chronometer for flame duration; analytical balance (precision ±0.1 grain) for pre- and post-calcination metal mass
Refuted if: If flame duration remains constant while metal mass gain varies (or vice versa) under controlled vessel volumes, or if the seconds-per-grain ratio shows no significant correlation (r < 0.5) across repeated trials with different metals or temperatures
Mechanism: Increasing sealed vessel volume increases the total pool of active air component. This component is simultaneously consumed by the flame (which it 'dissolves' per Hooke) and incorporated into the calcining metal (per Mayow/Boyle). Because both processes draw from the same finite atmospheric fraction in a fixed partition ratio, the total flame duration scales linearly with the mass of metal calx gained, making flame lifetime a direct proxy for solid-phase mass transfer.

Quantitative prediction: Systematically vary sealed vessel volume from 50 to 500 cubic inches while holding candle size and metal mass constant → increase 40–65 seconds/grain in Flame extinction time (seconds) per unit mass of metal calx gained (grains) · confidence 0.62 · support 3 / contra 0

The mass of phlogiston released during combustion is stoichiometrically proportional to the volume of the active air component consumed, yielding a material-independent constant ratio regardless of the fuel burned.

IV: Volume of the active air component consumed during combustion (measured as air depletion in a sealed vessel)
DV: Mass of phlogiston released from the combusting material (inferred from gravimetric mass loss of the fuel)
Measure: Volumetric air depletion via water/mercury displacement (L) and pre- to post-combustion fuel mass difference (g)
Refuted if: If the mass-of-phlogiston-per-volume-of-air-consumed ratio varies by more than 15% across different fuel types, or if regression of mass loss against air depletion yields R² < 0.80, the hypothesis is falsified
Mechanism: Hooke identifies a substance in common air that dissolves flame, and Mayow demonstrates that respiration and combustion both consume the same active air fraction. Boyle shows that combustion ceases once this air is 'spent' and that materials change weight during the process. The hypothesis traverses these claims by proposing that the active air component possesses a fixed phlogiston-accepting capacity; as combustion proceeds, phlogiston transfers from the fuel to this air component until saturation. Because the active component's capacity per unit volume is invariant, the total phlogiston released must scale linearly with the volume of active air consumed, independent of fuel identity.

Quantitative prediction: Burn 5 chemically distinct fuels (charcoal, sulfur, magnesium, iron, wax) in identical sealed vessels, recording air depletion and fuel mass loss at constant temperature and pressure → increase 2–4.5 g phlogiston per L active air consumed in Mass of phlogiston released from the combusting material (inferred from gravimetric mass loss of the fuel) · confidence 0.25 · support 4 / contra 1

Increasing weight produces a measurable change in when.

IV: weight
DV: when

compile errors: missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

Increasing calcined produces a measurable change in weight.

IV: calcined
DV: weight

compile errors: missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

Increasing calcined produces a measurable change in when.

IV: calcined
DV: when

compile errors: missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

Combustion of magnesium releases phlogiston, resulting in a net decrease in the mass of the solid residue.

IV: Combustion of magnesium metal (heating in air vs. unheated control)
DV: Mass of the solid residue after combustion
Measure: Gravimetric analysis using a precision balance (sensitivity 0.001 g) in an open crucible, measuring mass before and after ignition
Refuted if: If the mass of the residue is greater than or equal to the initial mass of the magnesium within experimental error, the hypothesis is falsified.
Mechanism: Magnesium is a 'phlogisticated' metal composed of a calx base bound to phlogiston. Upon heating, caloric energy overcomes the affinity binding phlogiston to the metal, causing phlogiston to volatilize and escape into the atmosphere. The remaining calx (oxide) possesses less mass than the original metal because the phlogiston component has been removed.

compile errors: missing:prediction, evidence:ungrounded (no source_ids)

There is a relationship between: 'Both respiration and combustion consume a specific fraction of the air.' and 'A finite quantity of the active air-component supports burning before it is exhausted.'.

compile errors: missing:independent_variable, missing:dependent_variable, missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

There is a relationship between: 'Combustion and the calcination of metals appear to consume something from the air.' and 'Metals gain weight when calcined in air.'.

compile errors: missing:independent_variable, missing:dependent_variable, missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction

There is a relationship between: 'Combustion and the calcination of metals appear to consume something from the air.' and 'Metals gain weight when calcined in air.'.

compile errors: missing:independent_variable, missing:dependent_variable, missing:measurement, missing:expected_outcome, missing:falsification_condition, missing:mechanism, missing:prediction